Releuko
Active Ingredient(s): Filgrastim-ayowFDA Approved: * February 25, 2022
Pharm Company: * KASHIV BIOSCIENCES LLC
Category: Cancer
Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count.[6] Low neutrophil counts may occur with HIV/AIDS, following chemotherapy or radiation poisoning, or be of an unknown cause.[6] It may also be used to increase white blood cells for gathering during leukapheresis.[6] It is given either by injection into a vein or under the skin.[6] Common side effects include fever, cou... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Releuko 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution
NDC: 70121-1568
Labeler:
Amneal Pharmaceuticals LLC
Releuko 300 ug/ml Intravenous; Subcutaneous Injection, Solution
NDC: 70121-1569
Labeler:
Amneal Pharmaceuticals LLC
Releuko 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution
NDC: 70121-1570
Labeler:
Amneal Pharmaceuticals LLC
Releuko 480 ug/1.6ml Intravenous; Subcutaneous Injection, Solution
NDC: 70121-1571
Labeler:
Amneal Pharmaceuticals LLC
